<DOC>
	<DOCNO>NCT00781742</DOCNO>
	<brief_summary>The purpose research study determine whether AZD6765 effect patient 's depression take together current depression medication . In addition , information gather well AZD6765 tolerate , investigate level AZD6765 level current depression medication blood . In addition , research staff determine AZD6765 mood calm effect ( feel ) .</brief_summary>
	<brief_title>AZD6765 Severe Major Depressive Disorder ( MDD ) IV</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Signed informed consent studyrelated procedure start . The patient previously diagnose Major Depressive Disorder ( MDD ) currently take antidepressant least 6 week . Patient history poor response 1 antidepressant ( addition antidepressant patient take enrollment ) exposure adequate dos maximum tolerated dos ≥4 week . Patient lifetime history schizophrenia , bipolar , psychosis psychotic depression . Patient lifetime history failure ECT therapy . Patient pregnant breast feeding . Length current episode depression exceed ≥2 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Depression</keyword>
	<keyword>Depressive Disorder</keyword>
	<keyword>MDD</keyword>
</DOC>